PDL BioPharma, Inc. Share-based Payment Arrangement, Expense
PDL BioPharma, Inc. reported Share-based Payment Arrangement, Expense of $132.00 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2011-11-09
- PDL BioPharma, Inc. share-based payment arrangement, expense for the quarter ending 2011-09-30 was $132.00K, a 20.48% decline year-over-year.
- PDL BioPharma, Inc. share-based payment arrangement, expense for the quarter ending 2011-06-30 was $74.00K, a 56.73% decline year-over-year.
- PDL BioPharma, Inc. share-based payment arrangement, expense for the quarter ending 2011-03-31 was $50.00K, a 73.40% decline year-over-year.
- PDL BioPharma, Inc. share-based payment arrangement, expense for the quarter ending 2010-12-31 was $137.00K, a 32.84% decline year-over-year.
- PDL BioPharma, Inc. share-based payment arrangement, expense for fiscal 2010 was $662.00K, a 19.37% decline from fiscal 2009.
- PDL BioPharma, Inc. share-based payment arrangement, expense for fiscal 2009 was $821.00K, a 90.65% decline from fiscal 2008.
- PDL BioPharma, Inc. share-based payment arrangement, expense for fiscal 2008 was $8.78M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2011-09-30 | $132.00K 10-Q · filed 2011-11-09 | $206.00K derived: sum of 2 quarters · filed 2011-11-09 | $256.00K 10-Q · filed 2011-11-09 | $393.00K derived: sum of 4 quarters · filed 2011-11-09 |
| 2011-06-30 | $74.00K 10-Q · filed 2011-07-29 | $124.00K 10-Q · filed 2011-07-29 | $261.00K derived: sum of 3 quarters · filed 2011-07-29 | $427.00K derived: sum of 4 quarters · filed 2011-11-09 |
| 2011-03-31 | $50.00K 10-Q · filed 2011-04-28 | $187.00K derived: sum of 2 quarters · filed 2011-04-28 | $353.00K derived: sum of 3 quarters · filed 2011-11-09 | $524.00K derived: sum of 4 quarters · filed 2011-11-09 |
| 2010-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $303.00K derived: sum of 2 quarters · filed 2011-11-09 | $474.00K derived: sum of 3 quarters · filed 2011-11-09 | $662.00K 10-K · filed 2011-03-01 |
| 2010-09-30 | $166.00K 10-Q · filed 2011-11-09 | $337.00K derived: sum of 2 quarters · filed 2011-11-09 | $525.00K 10-Q · filed 2011-11-09 | $729.00K derived: sum of 4 quarters · filed 2011-11-09 |
| 2010-06-30 | $171.00K 10-Q · filed 2011-07-29 | $359.00K 10-Q · filed 2011-07-29 | $563.00K derived: sum of 3 quarters · filed 2011-07-29 | $778.00K derived: sum of 4 quarters · filed 2011-07-29 |
| 2010-03-31 | $188.00K 10-Q · filed 2011-04-28 | $392.00K derived: sum of 2 quarters · filed 2011-04-28 | $607.00K derived: sum of 3 quarters · filed 2011-04-28 | |
| 2009-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $419.00K derived: sum of 2 quarters · filed 2011-03-01 | $821.00K 10-K · filed 2011-03-01 | |
| 2009-09-30 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-09 | $617.00K 10-Q · filed 2010-11-09 | ||
| 2009-06-30 | $402.00K 10-Q · filed 2010-07-29 | |||
| 2008-12-31 | $8.78M 10-K · filed 2011-03-01 |